Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVX701 in advanced CEA-expressing malignancies or Stage III colon cancer
NCT00529984Phase 2Completed
- Sponsor
- AlphaVax, Inc.
- Start
- Sep 2007
- Primary completion
- May 2010
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of avx701 in colorectal cancer (CRC), pancreatic cancer (PC), lung cancer, breast cancer, sponsored by AlphaVax, Inc.. Started Sep 2007; status: completed.
02
Drugs
avx701
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)lung cancerbreast cancer
Beyond the preview
Go deeper on NCT00529984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529984.